Fundz

Clarity Pharmaceuticals completes A$203M institutional placement to advance cancer treatments. This marks the company's largest funding round to date.

PRIVATEJul 28, 2025

Amount Raised

A$203 Million

Round Type

Funding Round

SydneyBiotechnologyHealth CareTherapeutics

Description

Clarity Pharmaceuticals has successfully raised A$203 million through an institutional placement. The company aims to expedite the development of its innovative cancer therapies using copper radioisotopes. This funding will enhance its clinical research capabilities and expand its pipeline. CEO Dr Jane Doe emphasized that the funding highlights investor confidence in their mission to revolutionize cancer treatment.

Quick answer

Clarity Pharmaceuticals raised A$203 Million in a Funding Round round, dated July 28, 2025. Clarity Pharmaceuticals is based in Sydney, New South Wales, Australia.

How much did Clarity Pharmaceuticals raise?
Clarity Pharmaceuticals raised A$203 Million in a Funding Round round on July 28, 2025.
What does Clarity Pharmaceuticals do?
Clarity Pharmaceuticals is a clinical-stage company focused on developing innovative cancer treatments using copper radioisotopes.
Where is Clarity Pharmaceuticals based and how big is it?
Clarity Pharmaceuticals is based in Sydney, New South Wales, Australia.
Who are the decision-makers at Clarity Pharmaceuticals?
Fundz holds 1 contact at Clarity Pharmaceuticals. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Clarity Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.

  • iRegene Therapeutics raised an undisclosed amount (Series B) on September 9, 2025.
  • Alchemab Therapeutics raised an undisclosed amount (Series A) on September 9, 2025.
  • Integra Therapeutics raised $13M (Funding Round) on September 8, 2025.
  • NRG Therapeutics raised $67M (Funding Round) on September 8, 2025.
  • MRM Health raised $64M (Series B) on September 4, 2025.
  • TNF Pharmaceuticals raised $7M on September 2, 2025.

Who to call at Clarity Pharmaceuticals, and when

A new round usually means Clarity Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Clarity Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Clarity Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Clarity Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Clarity Pharmaceuticals

Location

Sydney, New South Wales, Australia

About

Clarity Pharmaceuticals is a clinical-stage company focused on developing innovative cancer treatments using copper radioisotopes. The company aims to bring its therapies to market within the next two years. Clarity is expanding its pipeline and enhancing its clinical research capabilities to support its proprietary therapies. The focus on copper radioisotopes aligns with advancements in oncology to improve patient outcomes.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Clarity Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Clarity Pharmaceuticals's next move

See what Strategic adds

Clarity Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.